Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3751_Библиотеки_им_академика_М_И_Перельмана
.pdf
anatomyof,66,66
archaortography,68,68
asymptomaticlesions,66
atherosclerosis,66
clinicalevaluation,67–68
intervention
dosage,69–70
follow-up,72
procedures,70,71
invasivedigitalsubtractionangiography,68
morbidityandmortality,66
outcomes,72–73
subclavian/innominateangiography,68–69,69
symptomaticlesions,67,67
totalocclusions
antegradeandretrogradeapproach,72
brachialapproach,72
treatment,69
Subclavianstealsyndrome,67
Suctionembolectomy,353
SUPERBtrial,268–269
Superficialfemoralartery(SFA)disease
ACC/AHArecommendations,227
criticallimbischemia(CLI),214
endovasculartreatment(EVT),214–215
femoropopliteal(FP)segment,214
follow-up,226–227
openbypass,214
percutaneoustransluminalangioplasty(PTA),214
clinicaltrials,221–223,222t,223
drug-coatedballoons(DCB),223–224
drug-elutingstents(DES),223
UnitedStatesFoodandDrugAdministration(FDA),223–224
peripheralarterialdisease(PAD),214SeeAlsoPeripheralarterialdisease(PAD)
stenting
baremetalstents(BMS),224–225
drug-elutingstents(DES),225–226
polytetrafluoroethylene(PTFE)-coveredstents,225
Trans-AtlanticInter-SocietyConsensus(TASC)lesions,214
Superficialvenousdisease,legs
clinicaldiagnosis,371
clinicalpresentation,370
compressionstockings,396–397
cyanoacrylateglue(CAG)
https://t.me/med1917

application,402–403,403
eSCOPEStudy,403
endovenouslaserablation(EVLA),397
complications,398
treatment,398
etiologicfactors,371
evidence,397
mechanochemicalablation(MOCA)
ClariVeindevice,400
vs.RadiofrequencyAblation,401
radiofrequencyablation
complications,399
endothemalheat–inducedthrombosis(EHIT),399,400
MedtronicClosureFastdevice,398–399,399
VNUSClosureSystem,398
saphenofemoraljunction(SFJ),396
saphenousvein(GSV)reflux,396
sclerotherapy
liquid/foamapplication,401
varicoseveins,401
Varithena,402
treatment,371
Supracoronaryaneurysm,103
SurgeryvsThrombolysisforIschemiaoftheLowerExtremity(STILE)trial,305
Surgicalembolectomy,353
SymplicityHTN-1Study,190
SymplicityHTN-2Trial,191
SymplicityHTN-3Trial,191–192
Symptomaticextracranialcarotidarterystenosis,43
Syphilis,3
T
TAArgetthoracicstent-graft,136,139
TAAsSeeThoracicaorticaneurysms(TAAs)
TAGandCTAG,130–132,131
Targetlesionrevascularization(TLR),254,254,279
TCARSeeTranscarotidcarotidarteryrevascularization(TCAR)
TEESeeTransesophagealechocardiography(TEE)
TEVARSeeThoracicendovascularaorticrepair(TEVAR)
Thoracicaorticaneurysms(TAAs),128
aorticpseudoaneurysm,106–107
completearchresection,106
elephanttrunkprocedure,106
intramuralhematoma(IMH),107,107
https://t.me/med1917

long-termcomplications,103–104,104
Marfanoidaneurysm,103
opensurgery,106
pathophysiology,102
patternsof,102,103
penetratingaorticulcer(PAU),107,107
proteolyticenzymes,102
proximalhemiarchresection,106
pseudoaneurysms,102
supracoronaryaneurysm,103
surgicalintervention,104–105,106t
surgicaltreatment,105–106
tubularaneurysm,103
Thoracicaorticdissection,128–129
acutetypeAaorticdissections,100
aorticvalvereplacement,102
complication,100,101t
indications,100,101t
IRADregistry,100
riskfactors,99,100t
Thoracicendovascularaorticrepair(TEVAR),12,99,108,118–120
endografts
characteristics,130,131t
relay,135–136,135,137t–139t
TAGandCTAG,130–132,131
valiantthoracicstent-graftsystem,133–135,134
ZenithAlpha,133
ZenithTX2,132–133
endoleak,146–147,147t
extremityischemia,148
FoodandDrugAdministration(FDA),128
perioperativemortalityandmorbidity,146
renalinjury,144
spinalcordischemia,146
stroke,148
thoracicaorticaneurysms,128
thoracicaorticdissection,128–129
visceralischemia,148
Thoraflex™HybridAnte-Flo,118,119
Thoraflex™HybridPlexus,118,119
Thrombectomy,mechanical,18
acutebasilarocclusion,24–25
foranteriorcirculation,25
distalclots,25
https://t.me/med1917

posteriorcirculationstrokes,24–25
Thrombolysis,351–352
contraindicationsto,304
efficacy,302
“guidewiretraversaltest,”302–303
patientmonitoring,303
randomizedcontrolledtrials,304
RochesterTrial,304
techniques,303
Thrombolysisorperipheralarterialsurgery(TOPAS),304–305
Thrombosis,299
acute,299
in-situthrombosis,299
Thrombusfragmentation,352
Tissueplasminogenactivator(tPA),11
TLRSeeTargetlesionrevascularization(TLR)
TOPASSeeThrombolysisorperipheralarterialsurgery(TOPAS)
Trans-AtlanticInter-SocietyConsensus(TASC),214,299
Trans-AtlanticInter-SocietyConsensusdocumentII(TASCII),218,218t
Transcarotidcarotidarteryrevascularization(TCAR),60–61,61,62t
Transcathetervascularintervention,4
Transesophagealechocardiography(TEE),112
Transfemoralcarotidangioplasty,57,59t
Transradialcoronaryangiography,51–53
Traumaticcervicalvascularinjury
carotidblowout(CBO),51,54
CTA,51
pseudoaneurysmformation,51,52–53
Tubularaneurysm,103
Turbo-elitelaseratherectomycatheter,277,277
Turnersyndrome,76
U
Ultrasound-guidedfoamsclerotherapy,401
vs.endothermalablation,401
UnitedStatesNuclearRegulatoryCommission,6
Upperextremityintervention,11
V
ValiantPS-IDEendograft,110
Valiantthoracicstent-graftsystem,133–135,134
VALORIItrial,134–135
Varithena,402
Vascularaccesscomplications
https://t.me/med1917

accesssite
arterialocclusion,332–334
arteriovenousfistula(AVF),328–330
hematoma,326–328,327–328
pseudoaneurysms(PSAs),330–332,331
classification,326
hemorrhage,328
infection,334–335
retroperitoneal(RP)bleed,327–328,
328
VASTSeeVertebralArteryStentingTrial(VAST)
Venousthromboembolism(VTE)
andarterialthrombosisrisk,374
below-the-kneedeepveinthrombosisSeeIsolateddistaldeepveinthrombosis(IDDVT)
chronicdeepveinthrombosis,372–373
hypercoagulableworkup,372
magneticresonancevenography(MRV),374
May-Thurnersyndrome(MTS)
endovenoustreatmentoptions,386–388
surgicalmanagement,386
therapeuticanticoagulation,385
pharmacologicaltreatment
AmericanCollegeofChestPhysicianGuidelines,368–369
catheter-directedtherapy,369–370
parenteralanticoagulation,368
postthromboticsyndrome(PTS),368
recurrentvenousthromboembolism,368
statins
JupiterTrial,374
oralanticoagulation,375
plateletrecruitment,375
therapy,375
superficialvenousthrombosis,legs,370–371
ultrasound,373
VertebralArteryStentingTrial(VAST),49
Viabahnstentgrafts,266–267,267,268t
VIASTARtrial,266
Visceralischemia,148
VNUSClosureSystem,398
Vorapaxar,320
VTESeeVenousthromboembolism(VTE)
W
“Wakeup”strokes,21
https://t.me/med1917

Warfarin-AspirinSymptomaticIntracranialDiseaseStudy(WASID),49
W.L.GoreArchBranchdevice,116
Woundhealing,limbsalvage
acuteinflammatoryphase,340
chokevessels,342
extracellularmatrix,340
maturationphase,340
noninvasivevascularstudies,parameters,340
proliferativephase,340
rhomboidtranspositionalflap,342,342
splitthicknessskingrafting(STSG),341,341
X
X-rayimaging,2,3SeeAlsoAngiography;Fluoroscopy
Y
YUKON-BTKtrial,248
Z
ZenithAlphathoracicstentgraft,129,130,133
ZenithAscenddevice,110
ZenithTX2,132–133
ZilverPTX,226,247,248,249t,270,276
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана
